The Federal Circuit ruled Monday that the Patent Trial and Appeal Board incorrectly invalidated a Synopsys Inc. circuit patent, reversing a decision favoring ATopTech Inc., which recently filed for bankruptcy after being ordered to pay $30 million for infringing Synopsys’ copyrights.
Abbott Laboratories’ nearly fivefold increase on its AIDS drug Norvis has prompted calls from government officials for a compulsory license for a generic version of the drug before its patent expiration, the Wall Street Journal reported.
Canada will finally ratify intellectual property treaties it signed six years ago, government sources have told the media.
Agribusiness Monsanto Co. has filed a lawsuit against Swiss rival Syngenta AG for patent infringement, seeking to bar Syngenta from using technology used in producing a popular genetically modified corn.
A U.S. District Judge has ruled against Qualcomm in a long-running patent dispute with Maxim Integrated Products Inc., granting a partial summary judgment regarding Qualcomm's licensing agreements.
Japanese conglomerate Kao Corp. has filed a patent infringement lawsuit against NexPress Solutions Inc., a unit of Eastman Kodak Co., over its technology for printer toners.
The Regents of the University of California this week defended its “Eolas” patent at the U.S. Patent and Trademark Office, arguing that it should be allowed to retain the controversial patent at the center of a $521 million jury award against Microsoft Corp.
A panel of the U.S. House of Representatives heard arguments Wednesday for and against amending the 1998 Digital Millennium Copyright Act.
Philadelphia-based intellectual property boutique Caesar, Rivise, Bernstein, Cohen & Pokotilow has named three of its partners as shareholders of the firm.
Federal prosecutors have filed criminal charges against another former Boeing Co. employee in a probe into allegations that the company stole trade secrets from rival Lockheed Martin Corp. to win a multibillion-dollar rocket contract.
A coalition of activist groups has launched a campaign against what they see as an effort by the European Union’s Council of Ministers to secure passage of patent protection for software without approval of the European Parliament.
Gateway has fired a legal salvo in the mounting patent battle between two of the world’s top computer maker, suing rival Hewlett-Packard Co. for infringement of five of its patents.
Cephalon Inc. said in a regulatory filing to the U.S. Securities and Trade Commission that it plans to sue Sandoz Inc. over its Abbreviated New Drug Application (ANDA) for a generic form of modafinil, the active drug substance in its narcolepsy drug Provigil.
Japanese electronics and office supply maker Ricoh Co. has filed lawsuits against Taiwan's Lite-On Information Technology Corp., CMC Magnetics Corp. and their related firms over the use of optical disc-related technologies.
The U.S. Court of Appeals for the Federal Circuit has reversed a lower court’s decision to invalidate drug maker Elan's patent for controlled-release naproxen.
The U.S. Patent Board of Appeals and Patent Interferences has issued judgment in favor of auto parts supplier ArvinMeritor against Eaton Corporation on all claims in two related transmission patent interferences, ArvinMeritor said.
Japan will propose the establishment of a specialized intellectual property body at the Organization for Economic Cooperation and Development (OECD), according to local media reports.
Fueled by a rising volume of patent expirations, growth for generic drugs sales is expected to sharply outpace growth for branded drugs in the next few years, according to a new survey.
Expanding its patent litigation against one of its chief rivals, U.S. computer maker Hewlett-Packard has petitioned the U.S. International Trade Commission to block Gateway from importing computers.
Japan’s plans for a specialized intellectual property court have progressed quickly, with a tentative launch date now set for April 2005.
Ireland’s government, which currently holds the presidency of the European Union, has launched an effort to roll back controversial measures in a bill that would harmonize the way in which national patent laws deal with software innovations.